Company intelligence / Profile preview

WARF Therapeutics

Madison, Wisconsin, United Stateswarf.org ↗

Ownership: Private
Development stage: Preclinical

Overview

WARF Therapeutics advances early-stage drug candidates from academic research at UW–Madison through preclinical validation. Programs focus on demonstrating in vivo proof-of-concept before seeking licensing or partnerships for further clinical development. No clinical results have been published as all programs remain preclinical.

Therapeutic areas: OncologyOther
Modalities: Small moleculeRadiopharmaceutical
Industry: Biotech

Drug pipeline

5 assets

WT-7695

Preclinical

4 more assets in the full pipeline.

Request access →

Partnerships

University of Wisconsin–Madison researchers/principal investigatorsMorgridge Institute for Research principal investigatorsSHINE TechnologiesSanford Burnham Prebys Medical Discovery Institute

Beyond the preview

Go deeper on WARF Therapeutics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on WARF Therapeutics.

Explore the full profile